Article
Cancer Stem Cell Gene Variants Predict Disease Recurrence in Patients Treated with Radical Prostatectomy for Prostate Cancer.
International journal of medical sciences - 1 Jan 2017
Lin Victor C, Huang Shu-Pin, Huang Chao-Yuan, Yu Chia-Cheng, Yin Hsin-Ling, Huang Tsung-Yi, Lee Cheng-Hsueh, Lu Te-Ling, Bao Bo-Ying
Abstract excerpt
Background: Cancer stem cells (CSCs) are involved in tumor progression and drug resistance. We hypothesized that variants in CSC marker genes influence treatment outcomes in prostate cancer. Methods: Ten potentially functional single nucleotide polymorphisms (SNPs) in seven prostate CSC marker genes, TACSTD2, PROM1, ITGA2, POU5F1, EZH2, PSCA, and CD44, were selected for analysis of their association with disease...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
